Skip to content

NWBO NORTHWEST BIOTHERAPEUTICS INC.

Follow

USD (unknown), issuer CIK 1072379

8 managers (8 13F filers) reported a position in NWBO shares at 2026-03-31, 406,644 shares in all. 2 filers opened a position and 1 filer sold out during the quarter.

Managers
8
13F filers
8
New
2
Added
1
Reduced
1
Sold out
1
Shares held by filers
406,644

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
KELLEHER FINANCIAL ADVISORS200,000$41.3K0.01%new13F-HRTimeline
VSM Wealth Advisory, LLC80,574$16.6K<0.01%013F-HRTimeline
Opus Capital Group, LLC60,150$12K<0.01%013F-HRTimeline
Ethos Financial Group, LLC39,070$8.07K<0.01%+10,72013F-HRTimeline
Williams Jones Wealth Management, LLC.25,000$5.16K<0.01%-2,00013F-HRTimeline
McIlrath & Eck, LLC600$124<0.01%new13F-HRTimeline
Coston, McIsaac & Partners1,000$00%013F-HRTimelineValue filed as zero, left out of ratios.
HANTZ FINANCIAL SERVICES, INC.250$00%013F-HRTimelineValue filed as zero, left out of ratios. The filing omitted confidential holdings, a later amendment may add them.